An international clinical trial to test the first new cough drug in 50 years is being led by The University of Manchester’s Professor Jaclyn Smith. If approved, the promising new treatment could offer ...

If approved, gefapixant will compete with GSK Plc (NYSE: GSK)-owned camlipixant, currently in late-stage development for chronic cough treatment, Reuters added. With no FDA-approved therapies ...

It can be tricky to judge if a cough needs to be checked out by a medical professional and thankfully a doctor has weighed in ...

Here, we break down the most common causes of chronic cough in kids and explain treatment options for each. A chronic cough is typically defined as any type of cough that lasts more than four weeks.

Appropriate treatment for these factors resulted in a significant improvement in cough. Conclusion: Reflux, allergy, and asthma accounted for > 80% of the likely etiologic factors of chronic cough ...

Background: The burden of children's chronic cough to parents is largely unknown. The objectives of this study were as follows: (1) to determine the burden of chronic cough using a purposely ...

(Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary ...

s AI-powered cough detection technology, RCC is a condition that is estimated to afflict approximately 10% of the human population, with limited treatment options. Alkaline HDS aerosols ...